Testing effectiveness (Phase 2)Study completedNCT00869050What this trial is testingCapecitabine and Temozolomide for Neuroendocrine CancersWho this might be right forNeuroendocrine Tumors Columbia University 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT01841736What this trial is testingPazopanib Hydrochloride in Treating Patients With Progressive Carcinoid TumorsWho this might be right forForegut Neuroendocrine TumorHindgut Neuroendocrine TumorMetastatic Digestive System Neuroendocrine Tumor G1+5 more National Cancer Institute (NCI) 171
Not applicableEnded earlyNCT01130363What this trial is testingFundic Gland Polyps and Proton Pump Inhibitor (PPI) DrugsWho this might be right forFundic Gland Polyps Columbia University 23
Testing effectiveness (Phase 2)Study completedNCT00075439What this trial is testingGefitinib in Treating Patients With Progressive Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+6 more National Cancer Institute (NCI) 90
Large-scale testing (Phase 3)Active Not RecruitingNCT03375320What this trial is testingTesting Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsWho this might be right forFunctioning Pancreatic Neuroendocrine TumorIntermediate Grade Lung Neuroendocrine NeoplasmLocally Advanced Digestive System Neuroendocrine Neoplasm+25 more National Cancer Institute (NCI) 298
Testing effectiveness (Phase 2)Study completedNCT00602082What this trial is testingCapecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell Tumor Cambridge University Hospitals NHS Foundation Trust 84
Early research (Phase 1)WithdrawnNCT02831179What this trial is testingVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWho this might be right forFunctional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00017199What this trial is testingPS-341 in Treating Patients With Metastatic Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell Tumor Ohio State University Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Not applicableStudy completedNCT04028479What this trial is testingThe Registry of Oncology Outcomes Associated With Testing and TreatmentWho this might be right forAdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more Taproot Health 167
Very early researchActive Not RecruitingNCT04993261What this trial is testingAn Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid TumorsWho this might be right forCarcinoid SyndromeCarcinoid TumorDigestive System Neuroendocrine Tumor G1+1 more M.D. Anderson Cancer Center 71
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)WithdrawnNCT00227773What this trial is testingVatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell Carcinoma Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Ended earlyNCT00227617What this trial is testingCombination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more University of California, San Francisco 36
Testing effectiveness (Phase 2)Study completedNCT00093782What this trial is testingTemsirolimus in Treating Patients With Metastatic Neuroendocrine CarcinomaWho this might be right forMetastatic Gastrointestinal Carcinoid TumorPulmonary Carcinoid TumorRecurrent Gastrointestinal Carcinoid Tumor+1 more National Cancer Institute (NCI) 36
Not applicableLooking for participantsNCT05734430What this trial is testingGenetics of Appendix Cancer StudyWho this might be right forAppendix CancerAppendiceal CancerAppendiceal Neoplasms+12 more Andreana Holowatyj, PhD, MSCI 700
Testing effectiveness (Phase 2)Study completedNCT00002470What this trial is testingFluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid TumorsWho this might be right forGastrointestinal Carcinoid TumorLung Cancer Mid-Atlantic Oncology Program
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Study completedNCT02259725What this trial is testingRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+6 more University of Southern California 3